Health Catalyst (NASDAQ:HCAT) reported quarterly sales of $59.63 million which beat the analyst consensus estimate of $56.81 million by 4.96 percent. This is a 37.84 percent increase over sales of $43.26 million the same period last year.
JMP Securities Maintains Market Outperform on Plymouth Industrial REIT, Raises Price Target to $32
JMP Securities analyst Aaron Hecht maintains Plymouth Industrial REIT (NYSE:PLYM) with a Market Outperform and raises the price target from $26 to $32.
